Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 avr. 2004 07h30 HE | Source: Endovasc Inc.

Endovasc Announces Early Closure of Patient Recruitment for Liprostin Clinical Trial

MONTGOMERY, Texas, April 1, 2004 (PRIMEZONE) -- Endovasc Inc. (OTCBB:EVSC), a drug development company that pioneers new cardiovascular and metabolic drug therapies, announced today the completion of...
12 févr. 2004 16h00 HE | Source: Endovasc Inc.

Endovasc Provides Status Report on its $200 Million Case Against Alleged Stock Manipulators

MONTGOMERY, Texas , Feb. 12, 2004 (PRIMEZONE) -- Endovasc Inc. (OTCBB:EVSC), a drug development company that pioneers new cardiovascular and metabolic drug therapies, announced today an update on the...
28 janv. 2004 08h30 HE | Source: Endovasc Inc.

Two Clinical Sites in Mexico City Join Endovasc's Liprostin Phase II Trial

MONTGOMERY, Texas, Jan. 28, 2004 (PRIMEZONE) -- Endovasc Inc. (OTCBB:EVSC), a drug development company that pioneers new cardiovascular and metabolic drug therapies, announced today that...
22 janv. 2004 08h30 HE | Source: Endovasc Inc.

Endovasc Opens Four Sites in Moscow to Participate in Phase II Clinical Trial to Treat Patients Suffering from Peripheral Vascular Disease

MONTGOMERY, Texas, Jan. 22, 2004 (PRIMEZONE) -- Endovasc Inc. (OTCBB:EVSC), a drug development company that pioneers new cardiovascular and metabolic drug therapies, is pleased to announce that...